ATT Expands Fiber and Wireless Investments with Launch of New Flexible Plan London Stock Exchange Group Reports Income Growth Fueled by Tradeweb Performance Bitcoin ETFs See 1 Billion Outflows as Capital Rotates into HYPE SOL XRP Bond Market Rout Deepens Navigating the Volatility Surge AMD Plans 10 Billion Investment in Taiwans AI Chip Ecosystem to Propel NextGeneration Infrastructure Taiwan Arms Sales Emerges as Central Issue in TrumpXi Talks NewtekOne Inc NEWT Q1 2026 Earnings Earnings Miss but Stock Climbs on Optimism Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress Quantum Corporation QMCO Q1 2026 Earnings EPS Surpasses Expectations Amid Ongoing Restructuring Tandy Leather Factory Inc TLF Q1 2026 Earnings Small Profit Amid Quiet Quarter Okta Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Execution ESCA Q1 2026 Earnings EPS Surges 74 Above Estimates Stock Moves Higher Acumen Pharmaceuticals ABOS Holds Ground Near Resistance Can Biotech Momentum Continue Qiagen QGEN Holds Steady Above 35 as Biotech Sector Gains Momentum Generac Holdings GNRC Surges 7 as Energy Resilience Demand Gains Momentum Scully Royalty Ltd SRL Holds Steady at 612 as Traders Eye Key Resistance Eaton Vance Senior Income Trust EVF Holds Near Support After Minor Uptick Gold Fields Faces Cost Pressures Amid Geopolitical Tensions Yet Remains Highly Profitable SU Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Efficiency Gains Flag Ship Acquisition Corp Rights FSHPR Surge Over 46 Technical and Volume Analysis Enova International ENVA Shows Strength with 23 Gain Testing Key Resistance Levels Forafric Global Warrants AFRIW Consolidate Near Resistance at 080 Columbia Sportswear COLM Rallies 38 as Shares Bounce From Key Support Level Brookfield Business Corporation BBUC Holds Steady Near Resistance After Modest Gain Marvell Technology Gains Momentum MRVL Approaches Key Resistance After 29 Rally BWNB Senior Notes Hold Steady Near Support Technical and Fundamental View Eupraxia Pharmaceuticals EPRX Gains 279 as Stock Tests Resistance Near 775